Stay updated with breaking news from New Feasibility Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
22.09.2021 - Jetzt stehen alle Vorzeichen auf grün! Es geht der Produktion mit großen Schritten entgegen! Neuer Tagebau spart Millionen, direkter Hebel auf Kupfer lässt die Aktie steigen!
Share this article Share this article SAN DIEGO, Dec. 16, 2020 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic medical device and technology company focused on unmet needs in viral diseases, oncology and inflammation, announced today that the first patient has been treated in the Company's first-in-human Early Feasibility Study (EFS) evaluating the HEMOPURIFIER® in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. The study is enrolling patients at UPMC Hillman Cancer Center in Pittsburgh, PA. ( The EFS, which is the device equivale...